The World Orphan Drug Congress brought us together with the top stakeholders in rare and orphan disease. Here are our top three takeaways. Artificial Intelligence is here to stay. … Read More
From April 2020 to August 2021, the healthcare solutions company Indegene looked at approximately 7.9 million emails sent by prescription drug companies across 15 different email campaigns. The results, reported in April 2022 by Fierce Pharma, highlighted the need for brands to more carefully manage how they engage with healthcare providers in a post-COVID world … Read More
As a business leader, it might be tempting to delegate all things digital to your IT department. This is especially true among small businesses, for whom the IT “department” might consist of a single person. … Read More
With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. The pharmaceutical industry is no exception. … Read More
As a result, manufacturers are finally taking ownership of their patient journey technology stack. Their willingness to absorb painful system integration cycles have brought many to the conclusion that patient support services technologies should not and cannot be relegated to one-off patient-support vendors. … Read More
Our founder, Yishai Knobel was featured by MM+M regarding his thoughts on the top trends in 2023. To quote his comments from the larger article: “In 2023, forced to navigate trickier patient journeys and constrained marketing budgets, specialty patient services will be forced to rethink how to reach the 80% patients who never reach the Hub,” said RxWare CEO Yishai Knobel. … Read More